SYNLAB AG (SYAB.DE) Stock Fundamental Analysis
FRA:SYAB - Deutsche Boerse Ag - DE000A2TSL71 - Common Stock - Currency: EUR
SYAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 24 industry peers in the Health Care Providers & Services industry. SYAB has only an average score on both its financial health and profitability. SYAB is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SYAB had positive earnings in the past year.
In the past year SYAB had a positive cash flow from operations.
SYAB had positive earnings in 4 of the past 5 years.
SYAB had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.90%, SYAB is in line with its industry, outperforming 50.00% of the companies in the same industry.
SYAB has a Return On Equity of 3.77%. This is comparable to the rest of the industry: SYAB outperforms 42.31% of its industry peers.
With a Return On Invested Capital value of 2.03%, SYAB is not doing good in the industry: 73.08% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for SYAB is in line with the industry average of 6.26%.
The last Return On Invested Capital (2.03%) for SYAB is well below the 3 year average (6.36%), which needs to be investigated, but indicates that SYAB had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.9% | ||
| ROE | 3.77% | ||
| ROIC | 2.03% |
ROA(3y)5.43%
ROA(5y)4.23%
ROE(3y)12.69%
ROE(5y)11.89%
ROIC(3y)6.36%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 3.42%, SYAB is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
In the last couple of years the Profit Margin of SYAB has declined.
SYAB has a Operating Margin of 5.25%. This is comparable to the rest of the industry: SYAB outperforms 46.15% of its industry peers.
In the last couple of years the Operating Margin of SYAB has declined.
With a decent Gross Margin value of 76.87%, SYAB is doing good in the industry, outperforming 69.23% of the companies in the same industry.
In the last couple of years the Gross Margin of SYAB has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.25% | ||
| PM (TTM) | 3.42% | ||
| GM | 76.87% |
OM growth 3Y-37.83%
OM growth 5YN/A
PM growth 3Y-29.1%
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SYAB has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SYAB has about the same amout of shares outstanding than it did 1 year ago.
SYAB has a better debt/assets ratio than last year.
2.2 Solvency
SYAB has an Altman-Z score of 1.09. This is a bad value and indicates that SYAB is not financially healthy and even has some risk of bankruptcy.
SYAB has a worse Altman-Z score (1.09) than 69.23% of its industry peers.
The Debt to FCF ratio of SYAB is 5.23, which is a neutral value as it means it would take SYAB, 5.23 years of fcf income to pay off all of its debts.
SYAB has a Debt to FCF ratio of 5.23. This is in the better half of the industry: SYAB outperforms 73.08% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that SYAB is somewhat dependend on debt financing.
The Debt to Equity ratio of SYAB (0.59) is better than 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 5.23 | ||
| Altman-Z | 1.09 |
ROIC/WACC0.38
WACC5.32%
2.3 Liquidity
SYAB has a Current Ratio of 1.24. This is a normal value and indicates that SYAB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.24, SYAB is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that SYAB should not have too much problems paying its short term obligations.
The Quick ratio of SYAB (1.15) is better than 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.24 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 338.87% over the past year.
Measured over the past years, SYAB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -31.16% on average per year.
SYAB shows a decrease in Revenue. In the last year, the revenue decreased by -9.57%.
The Revenue has been growing slightly by 0.18% on average over the past years.
EPS 1Y (TTM)338.87%
EPS 3Y-31.16%
EPS 5YN/A
EPS Q2Q%-15.38%
Revenue 1Y (TTM)-9.57%
Revenue growth 3Y0.18%
Revenue growth 5YN/A
Sales Q2Q%-2.84%
3.2 Future
SYAB is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.16% yearly.
The Revenue is expected to grow by 5.87% on average over the next years.
EPS Next Y-36.39%
EPS Next 2Y-17.32%
EPS Next 3Y-0.11%
EPS Next 5Y24.16%
Revenue Next Year1.55%
Revenue Next 2Y3.79%
Revenue Next 3Y4.22%
Revenue Next 5Y5.87%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
SYAB is valuated quite expensively with a Price/Earnings ratio of 27.65.
SYAB's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of SYAB to the average of the S&P500 Index (26.68), we can say SYAB is valued inline with the index average.
A Price/Forward Earnings ratio of 30.12 indicates a quite expensive valuation of SYAB.
Based on the Price/Forward Earnings ratio, SYAB is valued a bit more expensive than the industry average as 65.38% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.50, SYAB is valued a bit more expensive.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.65 | ||
| Fwd PE | 30.12 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SYAB is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, SYAB is valued a bit cheaper than 73.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.23 | ||
| EV/EBITDA | 7.3 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.32%
EPS Next 3Y-0.11%
5. Dividend
5.1 Amount
SYAB has a Yearly Dividend Yield of 2.91%.
SYAB's Dividend Yield is rather good when compared to the industry average which is at 2.77. SYAB pays more dividend than 80.77% of the companies in the same industry.
SYAB's Dividend Yield is a higher than the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
86.39% of the earnings are spent on dividend by SYAB. This is not a sustainable payout ratio.
DP86.39%
EPS Next 2Y-17.32%
EPS Next 3Y-0.11%
FRA:SYAB (7/12/2024, 7:00:00 PM)
11.06
-0.02 (-0.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.43B
Analysts77.78
Price Target13.6 (22.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.91% |
Yearly Dividend0.35
Dividend Growth(5Y)N/A
DP86.39%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.23%
PT rev (3m)12.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-26.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.65 | ||
| Fwd PE | 30.12 | ||
| P/S | 0.93 | ||
| P/FCF | 8.23 | ||
| P/OCF | 5.8 | ||
| P/B | 1.02 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.3 |
EPS(TTM)0.4
EY3.62%
EPS(NY)0.37
Fwd EY3.32%
FCF(TTM)1.34
FCFY12.16%
OCF(TTM)1.91
OCFY17.23%
SpS11.9
BVpS10.79
TBVpS-1.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.9% | ||
| ROE | 3.77% | ||
| ROCE | 3.42% | ||
| ROIC | 2.03% | ||
| ROICexc | 2.2% | ||
| ROICexgc | 8.88% | ||
| OM | 5.25% | ||
| PM (TTM) | 3.42% | ||
| GM | 76.87% | ||
| FCFM | 11.3% |
ROA(3y)5.43%
ROA(5y)4.23%
ROE(3y)12.69%
ROE(5y)11.89%
ROIC(3y)6.36%
ROIC(5y)N/A
ROICexc(3y)7.75%
ROICexc(5y)N/A
ROICexgc(3y)61.71%
ROICexgc(5y)N/A
ROCE(3y)10.7%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-44.27%
ROICexc growth 5YN/A
OM growth 3Y-37.83%
OM growth 5YN/A
PM growth 3Y-29.1%
PM growth 5YN/A
GM growth 3Y1.23%
GM growth 5YN/A
F-Score7
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 5.23 | ||
| Debt/EBITDA | 2.79 | ||
| Cap/Depr | 34.22% | ||
| Cap/Sales | 4.72% | ||
| Interest Coverage | 1.49 | ||
| Cash Conversion | 84.16% | ||
| Profit Quality | 330.76% | ||
| Current Ratio | 1.24 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 1.09 |
F-Score7
WACC5.32%
ROIC/WACC0.38
Cap/Depr(3y)39.98%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.5%
Cap/Sales(5y)N/A
Profit Quality(3y)236.28%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)338.87%
EPS 3Y-31.16%
EPS 5YN/A
EPS Q2Q%-15.38%
EPS Next Y-36.39%
EPS Next 2Y-17.32%
EPS Next 3Y-0.11%
EPS Next 5Y24.16%
Revenue 1Y (TTM)-9.57%
Revenue growth 3Y0.18%
Revenue growth 5YN/A
Sales Q2Q%-2.84%
Revenue Next Year1.55%
Revenue Next 2Y3.79%
Revenue Next 3Y4.22%
Revenue Next 5Y5.87%
EBIT growth 1Y-32.69%
EBIT growth 3Y-37.72%
EBIT growth 5YN/A
EBIT Next Year179.46%
EBIT Next 3Y47.94%
EBIT Next 5Y37.1%
FCF growth 1Y-65.29%
FCF growth 3Y-17.53%
FCF growth 5YN/A
OCF growth 1Y-58.28%
OCF growth 3Y-11.12%
OCF growth 5YN/A